Who would get Regeneron's COVID-19 antibody treatment?

Retrieved on: 2020-11-05 01:15:00

Tags for this article:

Coronaviridae

Coronavirus disease

COVID-19 drug development

Leonard Schleifer

Medical specialties

Regeneron

Regeneron Pharmaceuticals

REGN-COV2

REGN-EB3

Sarbecovirus

Severe acute respiratory syndrome

Click the tags to see associated articles and topics

Who would get Regeneron's COVID-19 antibody treatment?. View article details on HISWAI:

Excerpt

<div><b>BioPharma</b> Dive Safety concerns lead Regeneron to halt testing of COVID-19 drug in some patients offsite link. Follow Jonathan Gardner on Twitter.</div>

Article found on:

View Original Article